Drug Type Small molecule drug |
Synonyms RG 6115, RO 7119929, RO7119929 |
Target |
Action agonists |
Mechanism TLR7 agonists(Toll like receptor 7 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gallbladder Neoplasms | Phase 1 | United States | 16 Jul 2020 | |
Gallbladder Neoplasms | Phase 1 | Denmark | 16 Jul 2020 | |
Gallbladder Neoplasms | Phase 1 | Hong Kong | 16 Jul 2020 | |
Gallbladder Neoplasms | Phase 1 | Spain | 16 Jul 2020 | |
Gallbladder Neoplasms | Phase 1 | Taiwan Province | 16 Jul 2020 | |
Klatskin Tumor | Phase 1 | United States | 16 Jul 2020 | |
Klatskin Tumor | Phase 1 | Denmark | 16 Jul 2020 | |
Klatskin Tumor | Phase 1 | Hong Kong | 16 Jul 2020 | |
Klatskin Tumor | Phase 1 | Spain | 16 Jul 2020 | |
Klatskin Tumor | Phase 1 | Taiwan Province | 16 Jul 2020 |
Phase 1 | 55 | (Part A1-1 mg RO7119929) | rtntczxtsd = gfmctjmasm ccpyewqawy (qiuqplwblj, kxvsciance - aaoilgsmon) View more | - | 09 Dec 2024 | ||
(Part A1-3 mg RO7119929) | rtntczxtsd = jmlqodxwbf ccpyewqawy (qiuqplwblj, hlgwmoxxfi - nlvughhwps) View more | ||||||
NCT04338685 (AACR2023) Manual | Phase 1 | 17 | (HCC ) | bnrprmfzkp(zmzjnjfyfq) = fvrqpbnsem hlzuxpobir (qyratgmmvo ) View more | Positive | 14 Apr 2023 |